When was Admetsys founded?

Admetsys was founded in 2014 and raised its 1st funding round within a year of its incorporation.

Where is Admetsys located?

Admetsys is headquartered in Boston, United States.

How many employees does Admetsys have?

As of Mar 31, 2026, the latest employee count at Admetsys is 3.

Is Admetsys a funded company?

Admetsys is a funded company, having raised a total of $50K across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 21, 2014.

When was the latest funding round of Admetsys?

Admetsys' latest funding was a $***** Seed round on Jun 06, 2017, with participation from 1 investor.

Where does Admetsys rank among its competitors?

Admetsys ranks 56th amongst 221 active competitors, of which 100 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was SS Innovations International, which secured $18.6M in Mar, 2026.

Who are the top competitors of Admetsys?

Admetsys' top competitors include Intuitive, Brainlab and PROCEPT BioRobotics. Among them, SS Innovations International secured the most recent funding round in March, 2026.

Admetsys - 2026 Company Profile, Team, Funding & Competitors

Admetsys is a seed company based in Boston (United States), founded in 2014 by Jeff Valk. It operates as a Provider of a closed-loop system for insulin and glucose delivery. Admetsys has raised $50K in funding from investors like MassChallenge, T1D Exchange and Dreamit. The company has 221 active competitors, including 100 funded and 29 that have exited. Its top competitors include companies like Intuitive, Brainlab and PROCEPT BioRobotics.

Company Details

Provider of a closed-loop system for insulin and glucose delivery. The companys' products provide hospitals with full automation of glucose monitoring and treatment and offer the precision and repeatability required by hospitals worldwide for this critical aspect of patient care. The “Admetsys Smart Pancreas” attaches to a patient’s existing intravenous line, where it automatically measures the blood glucose concentration in real-time and with no blood loss.

Website: admetsys.com
Social

Key Metrics

Founded Year

2014

Location

Boston, United States

Stage

Seed

Total Funding

$50K in 4 rounds

Latest Funding Round

Seed, Jun 06, 2017, $*****

Investors

MassChallenge & 7 more

Ranked

56^th among 221 active competitors

Employee Count

3 as on Mar 31, 2026

Similar Companies

Intuitive & 254 more

View Admetsys' full profile

Admetsys has raised a total funding of $50K over 4 rounds. Its first funding round was on May 21, 2014. Its latest funding round was a Seed round on Jun 06, 2017 for $*****. 1 investor participated in its latest round. Admetsys has 8 institutional investors.

Here is the list of recent funding rounds of Admetsys:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 06, 2017	2832781	Seed	1875110	8635363	5785707	2968446
Mar 24, 2016	4093601	Seed	8802604	3382974	5160294	2358750
Mar 09, 2015	8534370	Seed	9152364	7872225	8923918	TMCx Accelerator

Access funding benchmarks and valuations. Sign up today!

View details of Admetsys's funding rounds and investors

The founders of Admetsys is Jeff Valk.

Here are the details of Admetsys' key team members:

Jeff Valk: CEO & Co-Founder of Admetsys.

View details of Admetsys's Founder profiles and Board Members

Admetsys' employee count trend

Admetsys has 3 employees as of Mar 26. Here is Admetsys's employee count trend over the years:

Uncover Admetsys' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Admetsys include Intuitive, Brainlab and PROCEPT BioRobotics. Here is the list of Top 10 competitors of Admetsys, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Intuitive 1995, Sunnyvale (United States), Public	Developer of robotic-assisted surgical systems	$17M	Gershon Capital, ELM Responsible Investments ... & 10 others	81/100
2nd	Brainlab 1989, Munich (Germany), Series B	Software and integrated solutions for surgical and radiotherapy applications	$12.7M	EMH Partners, Intel Capital & 3 others	74/100
3rd	PROCEPT BioRobotics 2009, Redwood City (United States), Public	Developer of a therapeutic device for benign prostatic hyperplasia	$349M	Fidelity Investments, Viking Global Investors ... & 5 others	71/100
4th	Medical Microinstruments 2015, Calci (Italy), Series C	Provider of robotic platform using micro instruments for surgery	$210M	Deerfield, Fidelity Investments & 11 others	66/100
5th	SS Innovations International 2015, Gurugram (India), Seed	Developer of healthcare professional robots	$2.45M	ZSVC, Yijing Capital & 4 others	66/100
6th	CMR Surgical 2014, Cambridge (United Kingdom), Series D	Provider of collaborative surgical robotic systems	$1.32B	LGT Capital Partners, SoftBank Vision Fund ... & 37 others	65/100
7th	eCential Robotics 2009, Gieres (France), Series C	Developer of robotic surgery platform combining imaging, navigation, and robotic assistance	$134M	Bpifrance, Caisse D Epargne & 7 others	65/100
8th	ForSight Robotics 2020, Yokneam Illit (Israel), Series B	Provider of an AI-based ophthalmic surgical robot for healthcare professionals	$195M	Eclipse, Mithril & 6 others	64/100
9th	Neocis 2012, Miami (United States), Series D	Provider of robotic guidance system for dental surgeries	$179M	DFJ Growth, Norwest & 12 others	63/100
10th	Distalmotion 2012, Epalinges (Switzerland), Series G	Developer of robotic devices for surgical procedures	$390M	Revival Healthcare Capital, Zühlke & 10 others	62/100
56th	Admetsys 2014, Boston (United States), Seed	Provider of a closed-loop system for insulin and glucose delivery	$50K	Philips HealthWorks, TiE ScaleUp & 6 others	44/100